Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70220 ↗At a glance
Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Hassan Shabeer and 14 co-authors. Institution: Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan. Major MEDLINE topics: Drug-Eluting Stents, Coronary Artery Disease, Angioplasty, Balloon, Coronary, Coated Materials, Biocompatible. Cited 1 times so far (Crossref); 10 references. Funded by: The authors received no specific funding for this work..
Topics: Diabetes mellitus
Abstract (original language)
Background
The comparative outcomes of DEB vs. DES in diabetic patients undergoing PPCI are of significant clinical interest, as these patients often experience higher rates of restenosis and adverse outcomes.
Aims
This study aimed to compare the outcomes of drug‐eluting balloons (DEB) versus drug‐eluting stents (DES) in diabetic patients undergoing primary percutaneous coronary intervention (PPCI).
Methods
We conducted a retrospective analysis of 5668 diabetic patients who underwent PPCI, with 1734 patients in the DEB group and 3934 patients in the DES group. Baseline characteristics, angiographic features, and clinical outcomes, including procedural success, major adverse cardiovascular events (MACE), target lesion revascularization (TLR), restenosis, and bleeding complications, were compared between the two groups.
Results
Both DEB and DES groups demonstrated high procedural success rates (97.6% and 98.4%, respectively), with no significant differences in MACE, death, myocardial infarction, or target vessel revascularization. Restenosis at 6 months occurred in 3.9% of the DEB group and 3.4% of the DES group ( p = 0.21). Lesion length, diabetes duration, hypertension, and prior myocardial infarction were identified as significant predictors of adverse outcomes. Use of DES was associated with a higher risk of MACE, but this did not translate into significant differences in clinical outcomes.
Conclusion
Both DEB and DES are effective and safe treatment options for diabetic patients undergoing PPCI, with comparable outcomes in terms of procedural success, MACE, and restenosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
- Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.
ORCID profiles: Haimath Kumar, Muhammad Zaryab Haider, Ali Karim, Abida Parveen
Funding
- The authors received no specific funding for this work.
Cite
APA
Shabeer, H., Sattar, S., Arti, F. N. U., Kumar, H., Iltaf, K., Zaryab Haider, M., Haq Saqib, B. U., Hassan Bari, M., Karim, A., Kumar, S., Shweta, F. N. U., Payal, F. N. U., Rumela, F. N. U., Mastoi, M. G., & Parveen, A. (2025). Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70220
Vancouver
Shabeer H, Sattar S, Arti FNU, Kumar H, Iltaf K, Zaryab Haider M, et al. Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70220
BibTeX
@article{Shabeer2025,
author = {Shabeer, Hassan and Sattar, Saba and Arti, F N U and Kumar, Haimath and Iltaf, Kashif and Zaryab Haider, Muhammad and Haq Saqib, Burhan Ul and Hassan Bari, Muhammad and Karim, Ali and Kumar, Sameet and Shweta, F N U and Payal, F N U and Rumela, F N U and Mastoi, Mehak Gul and Parveen, Abida},
title = {Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70220}
}
EUVIMED